Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 30thDecember 2014
Summary The industry analysis specialist, has released its new report, “Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Osteoarthritis Pain Therapeutics market. The report identifies the key trends shaping and driving the global Osteoarthritis Pain Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Osteoarthritis Pain Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-osteoarthritis-oa-pain-therapeutics-pipeline-assessment-and-marketforecasts-135228 Scope The report provides information on the key drivers and challenges of the Osteoarthritis Pain Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Osteoarthritis Pain Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Osteoarthritis Pain Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Osteoarthritis Pain Therapeutics market. - Analysis of key recent licensing and partnership agreements in Osteoarthritis Pain Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Osteoarthritis Pain Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Osteoarthritis Pain Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Osteoarthritis Pain Therapeutics market landscape? – Identify, understand and capitalize. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Osteoarthritis Pain Therapeutics - Introduction 2.1 Disease Overview 2.1.1 Classification of Osteoarthritis 2.1.2 Types of Osteoarthritis 2.1.3 Osteoarthritis Pain 2.2 Epidemiology 2.2.1 Prevalence 2.3 Quality of Life 2.4 Etiology 2.5 Signs and Symptoms 2.6 Diagnosis 2.6.1 Physical Examination 2.6.2 Radiological Examination 2.6.3 Laboratory Test 2.7 Pathophysiology 2.7.1 Progression of the Disease 2.8 Treatment and Management Options 2.8.1 Pharmacological treatment Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.9 Referral Pathway 2.10 GlobalData Pipeline Report Guidance 3 Osteoarthritis Pain Therapeutics - Market Characterization 3.1 Overview 3.2 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – Global 3.3 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – Global 3.4 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – The US 3.5 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – The US 3.6 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – France 3.7 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – France 3.8 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – Germany 3.9 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – Germany 3.10 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – Italy 3.11 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – Italy 3.12 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – Spain 3.13 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – Spain 3.14 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – The UK 3.15 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – The UK 3.16 Osteoarthritis Pain Therapeutics Market Size (2006-2011) – Japan 3.17 Osteoarthritis Pain Therapeutics Market Forecast (2011-2019) – Japan 3.18 Drivers and Barriers for the Osteoarthritis Pain Therapeutics Market 3.18.1 Drivers for the Osteoarthritis Pain Therapeutics Market 3.18.2 Barriers for the Osteoarthritis Pain Therapeutics Market 3.19 Opportunity and Unmet Need Analysis 3.20 Key Takeaway 4 Osteoarthritis Pain Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Marketed Products in the Osteoarthritis Pain Therapeutics Market 4.3.1 Celebrex (celecoxib) 4.3.2 Voltaren Gel (diclofenac sodium) 4.3.3 Hyalgan (sodium hyaluronate) 4.3.4 Cymbalta (duloxetine) 4.3.5 Synvisc (hylan G-F 20) 4.4 Key Takeaway 5 Osteoarthritis Pain Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
5.3 Osteoarthritis Pain Therapeutics Pipeline – Pipeline by Phases of Development 5.3.1 Osteoarthritis Pain Therapeutics – Regulatory Filed Products 5.3.2 Osteoarthritis Pain Therapeutics – Phase III Pipeline 5.3.3 Osteoarthritis Pain Therapeutics – Phase II/III Pipeline 5.3.4 Osteoarthritis Pain Therapeutics – Phase II Pipeline 5.3.5 Osteoarthritis Pain Therapeutics – Phase I/II Pipeline 5.3.6 Osteoarthritis Pain Therapeutics – Phase I Pipeline 5.3.7 Osteoarthritis Pain Market – Discovery and Pre-Clinical Pipeline 5.3.8 Technology Trends Analytic Framework 5.4 Osteoarthritis Pain Therapeutics Market –Pipeline by Mechanism of Action 5.5 Molecule Profile for Promising Drugs Under Development 5.5.1 2 PX 5.5.2 Civanex 5.5.3 BEMA 5.5.4 CEP-33237 5.6 Key Takeaway 6 Osteoarthritis Pain Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (the US, EU5 and Japan) 6.2 Clinical Trials by Phase 6.3 Clinical Trials by Trial Status 6.4 Prominent Sponsors 6.5 Top Companies Participating in OA Pain Therapeutics Clinical Trials 7 Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Osteoarthritis Pain Therapeutics: Implications for Future Market Competition 8 Osteoarthritis Pain Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Winston Pharmaceuticals, Inc. 8.2.2 Teva Pharmaceuticals 8.2.3 Pfizer, Inc. 8.2.4 SantoSolvo AS 8.2.5 BioDelivery Sciences International, Inc. 8.2.6 Savient Pharmaceuticals, Inc. 8.2.7 Eli Lilly and Company 8.2.8 Horizon Pharma 8.2.9 Boehringer Ingelheim 9 Osteoarthritis Pain Therapeutics - Licensing and Partnership Deals 10 Osteoarthritis Pain Therapeutics - Appendix Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
10.1 Market Definitions 10.2 Abbreviations 10.3 Bibliography 10.4 Methodology 10.4.1 Coverage 10.4.2 Secondary Research 10.4.3 Forecasting 10.4.4 Primary Research 10.4.5 Expert Panel Validation 10.5 Contact Us 10.6 Disclaimer
List Of Tables Table 1: Prevalence rates of Osteoarthritis Pain by Country/Region Table 2: Prevalence Pool of Osteoarthritis Pain Patients in Seven Major Markets Table 3: Clinical Features of Osteoarthritis Pain Table 4: Classification Criteria for Osteoarthritis Pain Table 5: Treatment Options for Osteoarthritis Pain Table 6: Osteoarthritis Pain Therapeutics Market, Global, Revenue ($m), 2006–2011 Table 7: Osteoarthritis Pain Therapeutics Market, Global, Forecast ($m), 2011–2019 Table 8: Osteoarthritis Pain Therapeutics Market, The US, Revenue ($m), 2006–2011 Table 9: Osteoarthritis Pain Therapeutics Market, The US, Forecast ($m), 2011–2019 Table 10: Osteoarthritis Pain Therapeutics Market, France, Revenue ($m), 2006–2011 Table 11: Osteoarthritis Pain Therapeutics Market, France, Forecast ($m), 2011–2019 Table 12: Osteoarthritis Pain Therapeutics Market, Germany, Revenue ($m), 2006–2011 Table 13: Osteoarthritis Pain Therapeutics Market, Germany, Forecast ($m), 2011–2019 Table 14: Osteoarthritis Pain Therapeutics Market, Italy, Revenue ($m), 2006–2011 Table 15: Osteoarthritis Pain Therapeutics Market, Italy, Forecast ($m), 2011–2019 Table 16: Osteoarthritis Pain Therapeutics Market, Spain, Revenue ($m), 2006–2011 Table 17: Osteoarthritis Pain Therapeutics Market, Spain, Forecast ($m), 2011–2019 Table 18: Osteoarthritis Pain Therapeutics Market, The UK, Revenue ($m), 2006–2011 Table 19: Osteoarthritis Pain Therapeutics Market, The UK, Forecasts ($m), 2011–2019 Table 20: Osteoarthritis Pain Therapeutics Market, Japan, Revenue ($m), 2006–2011 Table 21: Osteoarthritis Pain Therapeutics Market, Japan, Forecasts ($m), 2011–2019 Table 22: Primary Efficacy Results for Synvisc: WOMAC Pain Score Table 23: Adverse Events Associated with Synvisc Table 24: Osteoarthritis Pain Therapeutics – Regulatory Filed Products, 2012 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 25: Osteoarthritis Pain Therapeutics – Phase III Pipeline, 2012 Table 26: Osteoarthritis Pain Therapeutics – Phase II/III Pipeline, 2012 Table 27: Osteoarthritis Pain Therapeutics – Phase II Pipeline, 2012 Table 28: Osteoarthritis Pain Therapeutics – Phase I/II Pipeline, 2012 Table 29: Osteoarthritis Pain Therapeutics – Phase I Pipeline, 2012 Table 30: Osteoarthritis Pain Therapeutics – Preclinical and Discovery Phase Pipeline, 2012 Table 31: Osteoarthritis Pain Therapeutics – Clinical Trials by Country, 2012 Table 32: Osteoarthritis Pain Therapeutics – Clinical Trials by Phase, 2012 Table 33: Osteoarthritis Pain Therapeutics – Clinical Trials by Status, 2012 Table 34: Osteoarthritis Pain Therapeutics, Overall Sponsors, 2012 Table 35: Osteoarthritis Pain Therapeutics, Most Prominent Sponsors, 2012 Table 36: Osteoarthritis Pain Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2012 Table 37: Winston Pharmaceuticals, Inc. Osteoarthritis Pain Pipeline, 2012 Table 38: Osteoarthritis Pain Therapeutics, Cephalon Inc./Teva Pharmaceuticals, Osteoarthritis Pain Therapeutics Pipeline, 2012 Table 39: Pfizer, Osteoarthritis Pain Pipeline, 2011 Table 40: Osteoarthritis Pain Therapeutics, SantoSolve Pain Management Pipeline, 2012 Table 41: Osteoarthritis Pain Therapeutics, BioDelivery Sciences Pain Management Pipeline, 2012 Table 42: Licensing and Partnership Deals, 2008-2011
List Of Figures Figure 1: Differentiation between Normal Joint and Osteoarthritis Joint Figure 2: Types of Osteoarthritis Pain Figure 3: Knee Osteoarthritis Figure 4: Osteoarthritis of Hand, Heberden’s Nodes and Bouchard’s Nodes Figure 5: Hip Osteoarthritis Figure 6: Examples of Disc Problems which Lead to Spine Osteoarthritis Figure 7: Joints and Bones of the Foot and Ankle Figure 8: Factors Affecting Degeneration of Cartilage Figure 9: Key Opinion Leader Insights, Diagnosis of Osteoarthritis Pain in the US and the UK. Figure 10: Progression of Osteoarthritis Pain Disease Figure 11: Key Opinion Leader Insights, Guidelines for Osteoarthritis Pain in the US and the UK Figure 12: Summary of Treatment Options for Osteoarthritis Pain Figure 13: Key Opinion Leader Insights, Treatment of Osteoarthritis Pain in the US and the UK Figure 14: Key Opinion Leader Insights, Pharmacological Treatment for Osteoarthritis Pain in Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
the US and the UK Figure 15: Management of Osteoarthritis of the Knee Figure 16: Management of Osteoarthritis of the Hip Figure 17: Referral Pathway for Osteoarthritis Pain Figure 18: Key Opinion Leader Insights, Referral Pathway for Osteoarthritis Pain in the US and the UK Figure 19: Osteoarthritis Pain Therapeutics Market, Global, Revenue ($m), 2006–2011 Figure 20: Osteoarthritis Pain Therapeutics Market, Global, Forecast ($m), 2011–2019 Figure 21: Osteoarthritis Pain Therapeutics Market, The US, Revenue ($m), 2006–2011 Figure 22: Osteoarthritis Pain Therapeutics Market, The US, Forecast ($m), 2011–2019 Figure 23: Osteoarthritis Pain Therapeutics Market, France, Revenue ($m), 2006–2011 Figure 24: Osteoarthritis Pain Therapeutics Market, France, Forecast ($m), 2011–2019 Figure 25: Osteoarthritis Pain Therapeutics Market, Germany , Revenue ($m), 2006–2011 Figure 26: Osteoarthritis Pain Therapeutics Market, Germany, Forecast ($m), 2011–2019 Figure 27: Osteoarthritis Pain Therapeutics Market, Italy, Revenue ($m), 2006–2011 Figure 28: Osteoarthritis Pain Therapeutics Market, Italy, Forecast ($m), 2011–2019 Figure 29: Osteoarthritis Pain Therapeutics Market, Spain, Revenue ($m), 2006–2011 Figure 30: Osteoarthritis Pain Therapeutics Market, Spain, Forecast ($m), 2011–2019 Figure 31: Osteoarthritis Pain Therapeutics Market, The UK, Revenue ($m), 2006–2011 Figure 32: Osteoarthritis Pain Therapeutics Market, The UK, Forecast ($m), 2011–2019 Figure 33: Osteoarthritis Pain Therapeutics Market, Japan, Revenue ($m), 2006–2011 Figure 34: Osteoarthritis Pain Therapeutics Market, Japan, Forecast ($m), 2011–2019 Figure 35: Key Opinion Leader Insights, Current Unmet Need for Osteoarthritis Pain in the US and the UK Figure 36: Opportunity and Unmet Need in the Osteoarthritis Pain Therapeutics Market, 2011 Figure 37: Key Opinion Leader Insights, Limitations with the Currently Available Treatment Options for Osteoarthritis Pain in the US and the UK Figure 38: Osteoarthritis Pain Therapeutics – Strategic Competitor Assessment, 2011 Figure 39: Key Opinion Leader Insights, Research for Future Treatment Options for Osteoarthritis Pain in the US and the UK Figure 40: Osteoarthritis Pain Therapeutics – Pipeline by Phase of Development, 2012 Figure 41: Osteoarthritis Pain Therapeutics – Technology Trends Analytics Framework, 2012 Figure 42: Osteoarthritis Pain Therapeutics – Technology Trends Analytics Framework – Description, 2012 Figure 43: Osteoarthritis Pain Therapeutics – Pipeline by Mechanism of Action, 2012 Figure 44: Key Opinion Leader Insights, Target Profile Testing for Osteoarthritis Pain in the US and the UK Figure 45: Osteoarthritis Pain Therapeutics – Clinical Trials by Country, 2012 Figure 46: Osteoarthritis Pain Therapeutics – Clinical Trials by Phase, 2012 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 47: Osteoarthritis Pain Therapeutics – Clinical Trials by Status, 2012 Figure 48: Osteoarthritis Pain Therapeutics – Overall Sponsors, 2012 Figure 49: Osteoarthritis Pain Therapeutics – Prominent Sponsors, 2012 Figure 50: Osteoarthritis Pain Therapeutics – Top Companies Participating in Therapeutics Clinical Trials, 2012 Figure 51: Osteoarthritis Pain Therapeutics Market, Drivers and Barriers 2011 Figure 52: Implications for Future Market Competition in the Osteoarthritis Pain Market, 2011 Figure 53: Osteoarthritis Pain Therapeutics Market – Pipeline by Company, 2012
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019 Toxoplasmosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Skin and Skin Structure Infections (SSSI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Athletes Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019 Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-osteoarthritis-oapain-therapeutics-pipeline-assessment-and-market-forecasts-135228
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/